The global micronucleus kits market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for micronucleus kits in various applications such as genotoxic carcinogens test and environmental carcinogens test. The genotoxic carcinogens test is used for determining the mutagenic potential of chemicals and drugs on human cells, whereas environmental carcinogens test is used for determining the mutagenic potential of chemicals on animal cells.
In Vitro Micronucleus Assay accounted for more than 50% share in 2018 owing to its high accuracy and low cost as compared with other methods such as flow cytometry or fluorescence-activated cell sorting (FACS). In Vivo Micronucleus Assay accounted for less than 10% share in 2018 owing to its high cost and low accuracy when compared with other methods such as flow cytometry or FACS. Genotoxic Carcinogens Test accounted for more than 50% share in 2018 owing to its wide application across various industries including pharmaceuticals, food & beverages, cosmetics & personal care products, agriculture & forestry products, construction materials etc, whereas Environmental Carcinogens Test accounted for less than 10% share in 2018 due to its limited application across industries such as agriculture & forestry products only. North America was estimated to account for more than 40% share in 2019 due to presence of major players operating within this region who are engaged into research activities related with micronucleus assay kits development which will help them gain competitive advantage over their competitors operating outside North America region.
- Increasing awareness about the Micronucleus Kits and its benefits among consumers is one of the major factors driving the growth of this market.
- The increasing number of research and development activities in this field is also driving the growth of this market.
- The increasing demand for Micronucleus Kits from various industries such as pharmaceuticals, food & beverage, cosmetics, etc, is also driving the growth of this market.
- Increasing government initiatives for promoting research in this field are expected to fuel the growth of this market.
Industry Growth Insights published a new data on “Micronucleus Kits Market”. The research report is titled “Micronucleus Kits Market research by Types (In Vitro Micronucleus Assay, In Vivo Micronucleus Assay), By Applications (Genotoxic Carcinogens Test, Environmental Carcinogens Test), By Players/Companies BD Biosciences, Charles River, BioReliance Corporation, Litron Laboratories, Thermo Fisher Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Micronucleus Kits Market Research Report
By Type
In Vitro Micronucleus Assay, In Vivo Micronucleus Assay
By Application
Genotoxic Carcinogens Test, Environmental Carcinogens Test
By Companies
BD Biosciences, Charles River, BioReliance Corporation, Litron Laboratories, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Micronucleus Kits Market Report Segments:
The global Micronucleus Kits market is segmented on the basis of:
Types
In Vitro Micronucleus Assay, In Vivo Micronucleus Assay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Genotoxic Carcinogens Test, Environmental Carcinogens Test
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD Biosciences
- Charles River
- BioReliance Corporation
- Litron Laboratories
- Thermo Fisher Scientific
Highlights of The Micronucleus Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- In Vitro Micronucleus Assay
- In Vivo Micronucleus Assay
- By Application:
- Genotoxic Carcinogens Test
- Environmental Carcinogens Test
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Micronucleus Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Micronucleus Kits are a type of cancer detection kit that uses a nucleic acid amplification test to detect the presence of micronuclei. Micronuclei are small, abnormal cells that can lead to cancer.
Some of the major companies in the micronucleus kits market are BD Biosciences, Charles River, BioReliance Corporation, Litron Laboratories, Thermo Fisher Scientific.
The micronucleus kits market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Micronucleus Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Micronucleus Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Micronucleus Kits Market - Supply Chain
4.5. Global Micronucleus Kits Market Forecast
4.5.1. Micronucleus Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Micronucleus Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Micronucleus Kits Market Absolute $ Opportunity
5. Global Micronucleus Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Micronucleus Kits Market Size and Volume Forecast by Type
5.3.1. In Vitro Micronucleus Assay
5.3.2. In Vivo Micronucleus Assay
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Micronucleus Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Micronucleus Kits Market Size and Volume Forecast by Application
6.3.1. Genotoxic Carcinogens Test
6.3.2. Environmental Carcinogens Test
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Micronucleus Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Micronucleus Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Micronucleus Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Micronucleus Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Micronucleus Kits Demand Share Forecast, 2019-2026
9. North America Micronucleus Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Micronucleus Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Micronucleus Kits Market Size and Volume Forecast by Application
9.4.1. Genotoxic Carcinogens Test
9.4.2. Environmental Carcinogens Test
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Micronucleus Kits Market Size and Volume Forecast by Type
9.7.1. In Vitro Micronucleus Assay
9.7.2. In Vivo Micronucleus Assay
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Micronucleus Kits Demand Share Forecast, 2019-2026
10. Latin America Micronucleus Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Micronucleus Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Micronucleus Kits Market Size and Volume Forecast by Application
10.4.1. Genotoxic Carcinogens Test
10.4.2. Environmental Carcinogens Test
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Micronucleus Kits Market Size and Volume Forecast by Type
10.7.1. In Vitro Micronucleus Assay
10.7.2. In Vivo Micronucleus Assay
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Micronucleus Kits Demand Share Forecast, 2019-2026
11. Europe Micronucleus Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Micronucleus Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Micronucleus Kits Market Size and Volume Forecast by Application
11.4.1. Genotoxic Carcinogens Test
11.4.2. Environmental Carcinogens Test
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Micronucleus Kits Market Size and Volume Forecast by Type
11.7.1. In Vitro Micronucleus Assay
11.7.2. In Vivo Micronucleus Assay
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. arket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Micronucleus Kits Demand Share, 2019-2026
12. Asia Pacific Micronucleus Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Micronucleus Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Micronucleus Kits Market Size and Volume Forecast by Application
12.4.1. Genotoxic Carcinogens Test
12.4.2. Environmental Carcinogens Test
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Micronucleus Kits Market Size and Volume Forecast by Type
12.7.1. In Vitro Micronucleus Assay
12.7.2. In Vivo Micronucleus Assay
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Micronucleus Kits Demand Share, 2019-2026
13. Middle East & Africa Micronucleus Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Micronucleus Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Micronucleus Kits Market Size and Volume Forecast by Application
13.4.1. Genotoxic Carcinogens Test
13.4.2. Environmental Carcinogens Test
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Micronucleus Kits Market Size and Volume Forecast by Type
13.7.1. In Vitro Micronucleus Assay
13.7.2. In Vivo Micronucleus Assay
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Micronucleus Kits Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Micronucleus Kits Market: Market Share Analysis
14.2. Micronucleus Kits Distributors and Customers
14.3. Micronucleus Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD Biosciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Charles River
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BioReliance Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Litron Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
